Epidemiological aspects of upper and lower respiratory tract infections during the COVID-19
- Authors: Pshenichnaya N.Y.1, Gopatsa G.V.1, Ugleva S.V.1, Sergevnin V.I1, Kudryavtseva L.G1, Lazarkov P.V1
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Issue: Vol 12, No 4 (2022)
- Pages: 72-76
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/288001
- DOI: https://doi.org/10.18565/epidem.2022.12.4.72-6
- ID: 288001
Cite item
Open Access
Access granted
Abstract
The review analyzes scientific articles and statistical data on changes in the etiological pattern and epidemiology of upper and lower respiratory tract infections during the COVID-19 pandemic. It is shown that the emergence and spread of SARS-CoV-2 during its pandemic through restrictive measures have affected significantly the global seasonal circulation of respiratory viruses. Uncontrolled and unreasonable use of antibacterial drugs, immunosuppressive therapy for COVID-19, and non-compliance with the anti-epidemic regimen in healthcare facilities have led to a change in the spectrum of community-acquired pneumonia pathogens and to the prevalence of multiresistant opportunistic bacteria and fungal flora as main etiological agents. It is necessary to strengthen the epidemiological surveillance of circulating respiratory viruses and also pathogens that cause lower respiratory tract diseases, as well as to elaborate strategies to combat antimicrobial resistance, and to control their implementation.
Full Text
About the authors
Natalia Yu. Pshenichnaya
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: natalia-pshenichnaya@yandex.ru
MD, Deputy Director for Clinical and Analytical Work
Galina V. Gopatsa
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-BeingCand. Med. Sci., Advisor, Organization and Guidance Department
Svetlana V. Ugleva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: uglevas@bk.ru
MD, Associate Professor, Consultant, Organization and Guidance Department, Administrative and Managerial Subdivision
V. I Sergevnin
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
L. G Kudryavtseva
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
P. V Lazarkov
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
References
- Moriyama M., Hugentobler W.J., Iwasaki A. Seasonality of respiratory viral infections. Annu. Rev. Virol. 2020; 7(1): 83-101. doi: 10.1146/annurev-virology-012420 -022445
- Авдеев С.Н., Белобородов В.Б., Белоцерковский Б.З., Грицан А.И., Дехнич А.В., Зайцев А.А. и др. Тяжелая внебольничная пневмония у взрослых. Клинические рекомендации Федерации анестезиологов и реаниматологов России. Анестезиология и реаниматология 2022; (1): 6-35. doi: 10.17116/anaesthesiology20220116
- Tang H.J., Lai C.C., Chao C.M. Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic. Antibiotics 2022; 11(3): 315. doi: 10.3390/antibio tics11030315
- https://www.iminfin.ru/areas-of-analysis/health
- Пшеничная Н.Ю., Журавлев Г.Ю., Лизинфельд И.А., Акимкин В.Г., Морозова Н.С., Малеев В.В. Влияние численности населения и географических факторов на заболеваемость острыми респираторными инфекциями в I. полугодии 2020 г. в регионах Российской Федерации в период пандемии COVID-19. Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(2): 6-12. doi: 10.18565/epidem.2021.11.2.6-12
- https://www.influenza.spb.ru/system/epidemic_situation/laboratory_diagnostics/
- Lorini Ch., Bonaccorsi G., Paget J., Caini S. The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature. Int. J. Environ. Res. Public Health 2020; 17(21): 7870. doi: 10.3390/ijerph17217870
- Taghioff S.M., Slavin B.R., Holton T., Singh D.Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. PLoS ONE 2021; 16(8): e0255541. doi: 10.1371/journal.pone.0255541
- Conlon А., Ashur С., Washer L., Kim A.E., Hofmann В.А. Impact of the influenza vaccine on COVID-19 infection rates and severity. American journal of infection control. 2021; 49(6): 694-700. doi: 10.1016/j.ajic. 2021.02.012
- Ferrero F., Ossorio M.F., Rial M.J. The return of RSV during the COVID-19 pandemic. Pediatric Pulmonology 2022; 57(3): 770-1. doi: 10.1002/ppul.25802
- Kieran D., Goldfarb D.M., Haney J., Amat J.A.R., Herder V. et al. Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology. J. Infect. Dis. 2021; 224(1): 31-8. doi: 10.1093/infdis/jiab147
- Torres A., Cilloniz C., Niederman M.S., Men6ndez R., Chalmers J.D., Wunderink R.G. et al. Pneumonia. Nat. Rev. Dis. Primers 2021; 7(1): 25. doi: 10.1038/s41572-021-00259-0.
- Alibert S., Dela Cruz C.S., Amati F., Sotgiu G., Restrepo M.I. Community-acquired pneumonia. Lancet 2021; 398(10303): 906-19. doi: 10.1016/s0140-6736(21)00630-9
- Попова А.Ю., Ежлова Е.Б., Демина Ю.В., Носков А.К., Ковалев Е.В., Карпущенко Г.В. и др. Этиология внебольничных пневмоний в период эпидемического распространения COVID-19 и оценка риска возникновения пневмоний, связанных с оказанием медицинской помощи. Здоровье населения и среда обитания 2021; (7): 67-75. doi: 10.35627/2219-5238/2021-29-7-67-75
- Троценко О.Е., Бондаренко А.П., Шмыленко В.А., Базыкина Е.А., Пшеничная Н.Ю., Зайцева Т.А. и др. Бактериальная микрофлора респираторного тракта, выявленная у больных внебольничной пневмонией в период продолжающегося распространения новой коронавирусной инфекции в г. Хабаровске (декабрь 2020 март 2021 г.). Инфекция и иммунитет 2022; 12(4): 713-25. doi: 10.15789/2220-7619-COR-1839.
Supplementary files
